A Phase II Feasibility Trial of Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Postoperative Radiotherapy in Patients With Malignant Pleural Mesothelioma.
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 17 Jul 2012 Additional lead trial center identified as reported by ClinicalTrials.gov.
- 17 Jul 2012 Actual end date (1 Aug 2007) added as reported by ClinicalTrials.gov.
- 31 Aug 2007 Status changed from recruiting to in progress.